While success still has many fathers, failure is no longer an orphan. President Obama’s recent speeches and rallies demonstrate that, now, failure is simply redefined as success. The costs from this revisionism is high. Creating false narratives encourage policies that will harm economic prosperity and...
There is no shortage of bad ideas when it comes to the pharmaceutical market. One such proposal would allow drugs to be imported directly from other countries, such as Canada. Then there is the Trump Administration’s proposal that would effectively adopt foreign price controls on...
Health and Human Services Secretary Alex Azar just released a sweeping proposal that would drastically change how Medicare pays for advanced cancer therapies and other potent medicines. The plan relies on foreign price controls to reduce drug spending by $17 billion over five years.
Although drug...
The SEC requires all institutional investors to vote on all matters put forth in proxy statements, or the measures voted on during shareholder meetings. For most institutional investors, keeping up with all of these issues is not feasible, so they turn to proxy advisory firms.
Proxy...
Rarely is there bipartisan agreement that a tax cut won’t cost the federal government money. But, in the case of the medical device tax (a 2.3 percent tax on medical devices and products that was passed as part of the Affordable Care Act) this is...
As part of the Affordable Care Act, a 2.3 percent tax on medical devices and products was passed. The tax was levied on devices such as pacemakers, advanced imaging technologies (Cat Scan, MRI and ultrasound equipment), artificial joints, surgical gloves, and dental instruments. Devices that...
Americans are facing two very different pension outlooks. Most private sector workers contribute to 401(k) plans (which are often matched by employers), and rely on investments, savings, and Social Security for their retirement. But, their savings is inadequate.
According to a 2018 survey by Northwestern Mutual, 33...
Calls for stricter environmental mandates contradict the broad public consensus on global warming.
According to a 2018 report by the Yale Program on Climate Change Communication, seven out of ten Americans believe global warming is happening and six out of ten say they are at least “somewhat...
Pfizer CEO Ian Read recently told investors that he believes pharmaceuticals will soon be sold without rebates. While this change, if it comes to pass, is undoubtedly positive for patients, a question naturally arises: why? After all, rebates and discounts are a normal part of...
Through its purchases of durable medical equipment (DME), the Centers for Medicare & Medicaid Services’ (CMS) helps many patients remain in their home and out of hospitals or other long-term care settings. These purchases cover a wide array of medical equipment including diabetes testing strips,...
Redefining Presidential Failure As Success
While success still has many fathers, failure is no longer an orphan. President Obama’s recent speeches and rallies demonstrate that, now, failure is simply redefined as success. The costs from this revisionism is high. Creating false narratives encourage policies that will harm economic prosperity and...
The Bizarre World of Drug Pricing
There is no shortage of bad ideas when it comes to the pharmaceutical market. One such proposal would allow drugs to be imported directly from other countries, such as Canada. Then there is the Trump Administration’s proposal that would effectively adopt foreign price controls on...
New Medicare Price Controls Don’t Put America First
Health and Human Services Secretary Alex Azar just released a sweeping proposal that would drastically change how Medicare pays for advanced cancer therapies and other potent medicines. The plan relies on foreign price controls to reduce drug spending by $17 billion over five years. Although drug...
The Law of Unintended Consequences: The Case of Proxy Advisory Firms
The SEC requires all institutional investors to vote on all matters put forth in proxy statements, or the measures voted on during shareholder meetings. For most institutional investors, keeping up with all of these issues is not feasible, so they turn to proxy advisory firms. Proxy...
Repeal the Medical Device Tax
Rarely is there bipartisan agreement that a tax cut won’t cost the federal government money. But, in the case of the medical device tax (a 2.3 percent tax on medical devices and products that was passed as part of the Affordable Care Act) this is...
The benefits of repealing the medical device tax
As part of the Affordable Care Act, a 2.3 percent tax on medical devices and products was passed. The tax was levied on devices such as pacemakers, advanced imaging technologies (Cat Scan, MRI and ultrasound equipment), artificial joints, surgical gloves, and dental instruments. Devices that...
The Opportunity Created by California’s Overly-Generous Public Pensions
Americans are facing two very different pension outlooks. Most private sector workers contribute to 401(k) plans (which are often matched by employers), and rely on investments, savings, and Social Security for their retirement. But, their savings is inadequate. According to a 2018 survey by Northwestern Mutual, 33...
CAFE Standards versus Public Opinion
Calls for stricter environmental mandates contradict the broad public consensus on global warming. According to a 2018 report by the Yale Program on Climate Change Communication, seven out of ten Americans believe global warming is happening and six out of ten say they are at least “somewhat...
Eliminate Pharmaceutical Rebates to Improve Patient Welfare
Pfizer CEO Ian Read recently told investors that he believes pharmaceuticals will soon be sold without rebates. While this change, if it comes to pass, is undoubtedly positive for patients, a question naturally arises: why? After all, rebates and discounts are a normal part of...
Reforming Medicare’s Competitive Bidding Program To Improve Health And Lower Costs
Through its purchases of durable medical equipment (DME), the Centers for Medicare & Medicaid Services’ (CMS) helps many patients remain in their home and out of hospitals or other long-term care settings. These purchases cover a wide array of medical equipment including diabetes testing strips,...